CAI - CIK 0002019410
Caris Life Sciences, Inc. (CAI) reported net income of -$68.09M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$68.09M | +75.8% |
| FY 2024 | -$281.89M | +17.4% |
| FY 2023 | -$341.42M | - |
Caris Life Sciences, Inc. (CAI) reported net income of -$68.09M for fiscal year 2025, as filed in its audited annual report with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.